24 May 2016 - The three drugs can all be used on their own if a person can’t use metformin or other specific drugs, and diet and exercise alone isn’t controlling their blood glucose levels.

Around 3 million people in the UK have type 2 diabetes. An estimated 31,000 people may be eligible for the three recommended treatments: canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance). The cost of a course of treatment over one year with each drug is around £475.

Adults currently receiving NHS treatment with canagliflozin, dapagliflozin or empagliflozin on its own that is not recommended for them in this guidance should be able to continue treatment until they and their NHS clinician consider it appropriate to stop.

For more details, go to: https://www.nice.org.uk/news/press-and-media/nice-recommends-three-diabetes-treatments